Twitter - Max International Virtual Office

esearch that received NIH and VA grants—and has resulted in numerous patents and patents-pending—is very close to
taking a prominent position in the marketplace, in what will be the first of many product releases in coming years.
On that subject, Dave recently had a conversation with a gentleman in the raw materials industry. The man, who worked
as a consultant with CellGevity, represents over $500 million in sales of raw materials and over $2 billion a year in the
wholesale marketplace. When the man asked how things were going with the CellGevity technology, Dave said we are
really close to making history in 2010. Having discussed it with many of his colleagues, the man concurred.
“This is technology that is going to blanket the earth,” Dave said.
Dave told of an experience in the board meeting with Dr. Herb Nagasawa who, in his characteristically straight-forward
way, said, “I just want to see my legacy, and this technology, help people in all quarters of the earth without the restriction
of a prescription.”
“That is his dream,” Dave said. “And you [the Associates] are the ones who will carry it to the world.
Many of you will reap the maximum benefits from this. You can make that important decision, which will
be your companion to a successful future and a healthy life.”
18